| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/16/2003 | WO2002011715A3 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/16/2003 | WO2002010406A3 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001068880A9 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/16/2003 | WO2001060778A3 Aspirin-triggered lipid mediators |
| 01/16/2003 | US20030013886 Such as (E)-1-(2-Pyridyl)-2-styryl-1H-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 01/16/2003 | US20030013875 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 01/16/2003 | US20030013770 Aminobenzophenones as inhibitors of il 1b and tnf |
| 01/16/2003 | US20030013754 Antiinflamamtory agents |
| 01/16/2003 | US20030013745 Urazole compounds useful as anti-inflammatory agents |
| 01/16/2003 | US20030013742 Antiinflammatory agents; skin disorders |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013718 Phthalazine derivatives for treating inflammatory diseases |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/16/2003 | US20030013712 Antiinflammatory agents |
| 01/16/2003 | US20030013704 Adamantane derivatives |
| 01/16/2003 | US20030013691 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 01/16/2003 | US20030013685 Process for increasing the egg production and strengthening the eggshells of poultry |
| 01/16/2003 | US20030013668 Antiarthritic agents; inflammatory bowel disease; multiple sclerosis |
| 01/16/2003 | US20030013658 Small peptides and methods for treatment of asthma and inflammation |
| 01/16/2003 | US20030013654 Administering polypeptide |
| 01/16/2003 | US20030013652 Releasing moderators for inflammation |
| 01/16/2003 | US20030013651 Stimulation of osteogenesis using rank ligand fusion proteins |
| 01/16/2003 | US20030013637 Novel anti-autoimmune composition by inhibition of GRF action |
| 01/16/2003 | US20030013179 Enzymatic polypeptide for use in the treatment of lysosomal storage disorders |
| 01/16/2003 | US20030013170 Inhibitors of receptor activator of NF-kappaB and uses thereof |
| 01/16/2003 | US20030013122 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/16/2003 | US20030012828 Topical medicine and process and apparatus for making same |
| 01/16/2003 | US20030012818 Bioactive molecule that is a non-glycosylated member of the cystine knot growth factor superfamily is physically entrapped in the polymeric matrix. |
| 01/16/2003 | US20030012793 Purified complex of heat shock protein noncovalently bound to a molecule. |
| 01/16/2003 | US20030012783 Interfere with the binding of a tumor necrosis factor receptor with its ligand; inhibiting the proliferation of tumor cells |
| 01/16/2003 | US20030012782 Method and composition for altering a T cell mediated pathology |
| 01/16/2003 | US20030012765 First polysaccharide crosslinked to second polysaccharide, selected from hyaluronic acid, dextran, dextran sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin, heparan sulfate and alginate |
| 01/16/2003 | CA2521993A1 Crystalline forms of ¬r-(r*,r*)|-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-¬(phenylamino)carbonyl|-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 01/16/2003 | CA2471232A1 Calcium l-threonate for preventing or treating bone fracture |
| 01/16/2003 | CA2471151A1 Calcium l-threonate for preventing or treating cartilage related diseases |
| 01/16/2003 | CA2453075A1 Drug metabolizing enzymes |
| 01/16/2003 | CA2452609A1 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 01/16/2003 | CA2452603A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 01/16/2003 | CA2452597A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 01/16/2003 | CA2452590A1 Morpholine-bridged pyrazolopyridine derivatives |
| 01/16/2003 | CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | CA2451749A1 Novel immunomodulating compounds |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | CA2451374A1 Aggrecanase molecules |
| 01/15/2003 | EP1275635A1 Calcium receptor-active compounds |
| 01/15/2003 | EP1275398A1 Diagnostics and remedies for rheumatoid arthritis |
| 01/15/2003 | EP1275388A1 Tnf- alpha inhibitors |
| 01/15/2003 | EP1274980A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 01/15/2003 | EP1274862A1 Control of a gene induced by oxidized lipids in human artery wall cells |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274840A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274730A2 Integrin/adhesion antagonists |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274705A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274700A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 01/15/2003 | EP1274697A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 01/15/2003 | EP1274694A1 Novel compounds |
| 01/15/2003 | EP1274692A1 Quinazoline compounds |
| 01/15/2003 | EP1274675A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/15/2003 | EP1274456A2 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies |
| 01/15/2003 | EP1274450A2 Cytokine uses; compositions; methods |
| 01/15/2003 | EP1274446A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 01/15/2003 | EP1274428A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274426A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
| 01/15/2003 | EP1274424A1 Compounds and methods |
| 01/15/2003 | EP1274416A1 Dermatological use and a dermatological preparation |
| 01/15/2003 | EP1274415A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274413A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274408A2 Use of natural chrysanthone compounds having antiangiogenic activity |
| 01/15/2003 | EP1274407A2 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 01/15/2003 | EP1169317B1 Triarylimidazoles |
| 01/15/2003 | EP1059933B1 Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture |
| 01/15/2003 | EP0937057B1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | EP0584347B1 Enantiomeric hydroxylated xanthine compounds |
| 01/15/2003 | CN1391605A Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/15/2003 | CN1391576A Androgen receptor modulator compounds and methods |
| 01/15/2003 | CN1391571A Heterocyclic compounds and their use as medicines |
| 01/15/2003 | CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 01/15/2003 | CN1391557A 6-position substituted indoline, production and use thereof as medicament |
| 01/15/2003 | CN1391556A IL-8 receptor antagonists |
| 01/15/2003 | CN1391479A Medicament for inducing tolerance |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1391464A Formulation for menopausal women |
| 01/15/2003 | CN1390605A Medicine C-AEDP using C as carrier for target therapy of osteopath and its usage |
| 01/15/2003 | CN1390596A Mayi-shuangshen Tongbi pill for treating rheumatoid or rheumatic arthitis and ankylosing spondylitis |
| 01/15/2003 | CN1390594A Mixture for improving blood circulation |
| 01/15/2003 | CN1390569A Pill for relieving rigidity of muscles and joints |
| 01/15/2003 | CN1390568A Capsule fr promoting blood circulation and removing obstruction in channel |
| 01/15/2003 | CN1390566A Shehu-Qiangzhuang pill for building up body |
| 01/15/2003 | CN1390563A Oral liquid 'Zhuibixiao' |
| 01/15/2003 | CN1098849C 噻唑衍生物 Thiazole derivatives |